research Identification of drug-specific public TCR driving severe cutaneous adverse reactions
Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.
Search
forClinics
6 / 12 results- 56Hair Loss TreatmentsDermatologyDra Fernanda Dagir Cosenza, Dermatologista e TricologistaSão Paulo, SP · BR
- 26
Hair TransplantClínica Vanusa Decker - Estética e SpaGuarapuava, PR · BR - 4
Hair TransplantCasa di Cura Villa AzzurraSiracusa · IT - 42
Hair TransplantHair Loss TreatmentsSMPCentre de Greffe Capillaire Saint MaurMarne La Vallée · FR - 53
Hair TransplantHair Loss TreatmentsCentre de Greffe de Cheveux NiceNice · FR - 66
Hair TransplantInstitut de Greffe de Cheveux du QuébecQuébec, QC · CA
Experts
6 / 19 results- 63
DermatologistFernanda Dagir Cosenza, MD
São Paulo, SP, Brazil
- 64
Hair Loss SpecialistTakara Nicole
Richmond Hill, GA, United States
- 40
Hair Transplant SurgeonDr. Diwakar Sharma, MD
Ahmedabad, Gujarat, India
- 53Hair Transplant Surgeon
Dr. Tawkir Chowdhury, MBBS, MS, MCh
Kolkata, West Bengal, India
- 34
Hair Transplant SurgeonDr. Tawkir Chowdhury, MBBS, MS, MCh, FRCS
Dehradun, Uttarakhand, India
- 27
Hair Transplant SurgeonAmanda Decker, MD
Florianópolis, SC, Brazil
Research
5 / 1000+ results research Multiplex matrix network analysis of protein complexes in the human TCR signalosome
Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.
research Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the disease
Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.
research 057 Single cell RNA and TCR sequencing reveals hyperexpansion of T cell clones and novel regulatory mechanisms of CD8+ T cells in murine alopcecia areata skin and draining lymph nodes
CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.
research 572 Development of immunotherapies targeting TCR-Vβ2 for treatment of cutaneous T cell lymphoma
Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.
Learn
— no results
Community Join
— no results